These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36524967)
1. Mechanistic Insights into the Superior DNA Delivery Efficiency of Multicomponent Lipid Nanoparticles: An In Vitro and In Vivo Study. Quagliarini E; Wang J; Renzi S; Cui L; Digiacomo L; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Amenitsch H; Masuelli L; Bei R; Pozzi D; Amici A; Cardarelli F; Marchini C; Caracciolo G ACS Appl Mater Interfaces; 2022 Dec; 14(51):56666-56677. PubMed ID: 36524967 [TBL] [Abstract][Full Text] [Related]
2. Investigating the mechanism of action of DNA-loaded PEGylated lipid nanoparticles. Digiacomo L; Renzi S; Quagliarini E; Pozzi D; Amenitsch H; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Cardarelli F; Caracciolo G Nanomedicine; 2023 Sep; 53():102697. PubMed ID: 37507061 [TBL] [Abstract][Full Text] [Related]
3. Efficient Delivery of DNA Using Lipid Nanoparticles. Cui L; Renzi S; Quagliarini E; Digiacomo L; Amenitsch H; Masuelli L; Bei R; Ferri G; Cardarelli F; Wang J; Amici A; Pozzi D; Marchini C; Caracciolo G Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015328 [TBL] [Abstract][Full Text] [Related]
4. Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery. Quagliarini E; Renzi S; Digiacomo L; Giulimondi F; Sartori B; Amenitsch H; Tassinari V; Masuelli L; Bei R; Cui L; Wang J; Amici A; Marchini C; Pozzi D; Caracciolo G Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452253 [TBL] [Abstract][Full Text] [Related]
6. Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology. Ottonelli I; Adani E; Bighinati A; Cuoghi S; Tosi G; Vandelli MA; Ruozi B; Marigo V; Duskey JT Int J Nanomedicine; 2024; 19():4235-4251. PubMed ID: 38766661 [TBL] [Abstract][Full Text] [Related]
7. Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. Maeki M; Uno S; Sugiura K; Sato Y; Fujioka Y; Ishida A; Ohba Y; Harashima H; Tokeshi M ACS Appl Mater Interfaces; 2024 Jan; 16(2):2110-2119. PubMed ID: 38141015 [TBL] [Abstract][Full Text] [Related]
8. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery. Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806 [TBL] [Abstract][Full Text] [Related]
9. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery. Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697 [TBL] [Abstract][Full Text] [Related]
10. Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery: Comirnaty and Drug-Free Dispersions. Unruh T; Götz K; Vogel C; Fröhlich E; Scheurer A; Porcar L; Steiniger F ACS Nano; 2024 Apr; 18(13):9746-9764. PubMed ID: 38514237 [TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311 [TBL] [Abstract][Full Text] [Related]
12. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge. Huang X; Chau Y Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery. Mashal M; Attia N; Maldonado I; Enríquez Rodríguez L; Gallego I; Puras G; Pedraz JL Eur J Pharm Biopharm; 2024 Aug; 201():114385. PubMed ID: 38945408 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery. Qin Y; Walters AA; Rouatbi N; Wang JT; Abdel-Bar HM; Al-Jamal KT Biomaterials; 2023 Aug; 299():122158. PubMed ID: 37243988 [TBL] [Abstract][Full Text] [Related]
15. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery. Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654 [TBL] [Abstract][Full Text] [Related]